The neonatal window of opportunity—early priming for life - 05/04/18
Doi : 10.1016/j.jaci.2017.11.019
Harald Renz, MD, PhD a, ⁎ 
, Becky D. Adkins, MD b, Sina Bartfeld, PhD c, Richard S. Blumberg, MD, PhD d, Donna L. Farber, MD, PhD e, Johan Garssen, MD, PhD f, Peter Ghazal, MD, PhD g, David J. Hackam, MD h, Benjamin J. Marsland, MD, PhD i, Kathy D. McCoy, MD, PhD j, John Penders, MD, PhD k, Immo Prinz, MD, PhD l, Valerie Verhasselt, MD, PhD m, Erika von Mutius, MD, MSc n, o, Jeffrey N. Weiser, MD p, Duane R. Wesemann, MD, PhD q, Mathias W. Hornef, MD r
, Becky D. Adkins, MD b, Sina Bartfeld, PhD c, Richard S. Blumberg, MD, PhD d, Donna L. Farber, MD, PhD e, Johan Garssen, MD, PhD f, Peter Ghazal, MD, PhD g, David J. Hackam, MD h, Benjamin J. Marsland, MD, PhD i, Kathy D. McCoy, MD, PhD j, John Penders, MD, PhD k, Immo Prinz, MD, PhD l, Valerie Verhasselt, MD, PhD m, Erika von Mutius, MD, MSc n, o, Jeffrey N. Weiser, MD p, Duane R. Wesemann, MD, PhD q, Mathias W. Hornef, MD r a University of Marburg, Marburg, Germany
b University of Miami, Miami, Fla
c University of Würzburg, Würzburg, Germany
d Harvard University, Cambridge, Mass
e Columbia University Medical Center, New York, NY
f Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands
g University of Edinburgh, Edinburgh, United Kingdom
h Johns Hopkins University, Baltimore, Md
i University Hospital of Lausanne, Lausanne, Switzerland
j University of Calgary, Calgary, Canada
k Care and Public Health Research Institute (Caphri) & NUTRIM School for Nutrition and Translational Research in Metabolism, Department of Medical Microbiology, Maastricht University, Maastricht, The Netherlands
l Hannover Medical School, Hannover, Germany
m Family Larsson-Rosenquist Foundation Chair in Human Lactology, School of Molecular Science, University of Western Australia, Perth, Australia
n Dr von Hauner Children's Hospital, Ludwig Maximilians University Munich, Munich, Germany
o Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Germany
p New York University School of Medicine, New York, NY
q Harvard University, Brigham and Women's Hospital, Boston, Mass
r RWTH University Hospital, Aachen, Germany
∗Corresponding author: Harald Renz, MD, PhD, Institute of Laboratory Medicine, University of Marburg, Baldingerstr, 35043 Marburg, Germany.Institute of Laboratory MedicineUniversity of MarburgBaldingerstrMarburg35043Germany
Le texte complet de cet article est disponible en PDF.
Plan
| The conference and the preparation of this manuscript were supported by an unrestricted grant of the Volkswagen Foundation, Hannover, Germany. J.G. receives grants from Nutricia Research Foundation, Dutch government funding (NWO, CCC, STW, RAAK/PRO, TKI), the European Union, and EDB. Research in M.W.H.’s laboratory is supported by the German Research Foundation (SPP1656, SPP1580, IRTG1273, and Ho-2237/12-1) and the Niedersachsen Research Network on Neuroinfectiology (N-RENNT). K.D.M. is supported by a grant from the SNSF (SNSF310030_134902) and the European Research Council (FP/2007-2013) agreement number 281785. J.P. is supported by a VIDI grant from the Netherlands Organisation for Scientific Research and a Joint Programme Initiatives grant (Intestinal Microbiomics GI-MDH) within the Healthy Diet for Healthy Living programme. I.P. is supported by the grant of the SFB900 (project B8). H.R. is supported by the German Lung Center, Disease Area of Allergy and Asthma. E.M. receives research grants from the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF). |
|
| Disclosure of potential conflict of interest: J. Garssen received Dutch government grants (STW, NWO, RAAK/PRO, CCC) and a Nutricia Research Foundation grant for this work. P. Ghazal has a patent for Molecular Predictors of Sepsis. D. J. Hackam has a patent pending, Agents for treating necrotizing enterocolitis. K. D. McCoy received a Swiss National Science Foundation grant and a European Research Council grant for this work. I. Prinz received SFB900, project SFB900, and project B8 from Deutsche Forschungsgemeinschaft for this work. E. von Mutius received consultancy fees from PharmaVentures, OM Pharma, Decision Resources, and Novartis Pharma SAS; assessment fees from the Chinese University of Hongkong and the University of Copenhagen; speaker's fees from HAL Allergie GmbH, Ökosoziales Forum Oberösterreich, Mundipharma, the American Thoracic Society, and AbbVie Deutschland GmbH & Co KG; expert witness fees from the University of Tampere and the European Commission; and honorarium from the Massachusetts Medical Society and the American Academy of Allergy, Asthma & Immunology. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 4
P. 1212-1214 - avril 2018 Retour au numéro
Article précédent
- News Beyond Our Pages
- Marc E. Rothenberg, Jean Bousquet
- Biodiversity: The new kid on the block?
- Erika von Mutius
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?